You are viewing the site in preview mode

Skip to main content

Advertisement

Table 1 Patient baseline characteristics

From: Combination of peptide receptor radionuclide therapy with fractionated external beam radiotherapy for treatment of advanced symptomatic meningioma

Pat. no. Age (y) Sex WHO grade Karnofsky score Meningioma location Prior Resection Prior RT Mag3 Clearance (% of norm) PTV (ml) Indication for intensified protocol / clinical presentation
1 27 f II 90 Right sphenoid wing 2 - 67.7 115 Large tumor, grade II, age/ pituitary insufficiency, decreased vision /ptosis
2 55 f I 100 Both sphenoid wings 1 0 82.4 223 Very large tumor / retroorbital pressure,
3 68 f NA* 90 Left petroclival 0 0 73.9 73 Critical location / Paresis of CN III, VI & VII
4 53 f I 80 Right sphenoid wing 2 0 87.1 38 Critical location / exophthalmus and chemosis right eye, progressive loss of vision
5 52 f I 100 Both sphenoid wings 1 0 61.7 197 Large tumor critical location /, progressive loss of vision
6 65 f I 100 Right sphenoid wing 1 0 83.2 29.3 Critical location /trigeminal hypesthesia
7 62 f I 80 Left falx & vertexregion 1 0 89.4 139 Clear-cell component, quickly progressive hemiparesis
8 63 m II 90 Falx central region 1 1 112.7 28 Previous RT, Grade II, large tumor / paresis left leg
9 69 f I 90 Left olfactory nerve & neurinoma of ethmoidal sinus§ 1 0 82.9 121 Large tumor/ epilepsy, tremor
10 67 m I 90 Multifocal bifrontal to right sphenoid wing 2 0 108.3 294 Ver large tumor/ dizziness, swelling and ptosis right palpebra
  1. * Biopsy not possible.
  2. § SSR-expression only in the meningioma, radiotherapy of both, meningioma and neurinoma.
  3. # Ga-DOTATOC.
  4. + Ga-DOTATATE.
  5. CN = Cranial Nerve.